Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human PAX8 ELISA Kit (AC3434)
Cat.#: ASET-2023
Specifications
Description Human PAX8 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human PAX8 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.018 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.4-6.4 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2188 Human ProSAAS ELISA Kit (AC3599) Quantitative inquiry ASET-2426 Human GABRD ELISA Kit (AC3837) Quantitative inquiry ASET-1162 Human DCC ELISA Kit (AC2573) Quantitative inquiry ASET-1663 Human EMP3 ELISA Kit (AC3074) Quantitative inquiry ASET-1859 Human G-Protein Coupled Receptor 30 ELISA Kit (AC3270) Quantitative inquiry ASET-1917 Human Leptin ELISA Kit (AC3328) Quantitative inquiry ASET-1320 Porcine Myelin Basic Protein ELISA Kit (AC2731) Quantitative inquiry ASET-1189 Rat Renalase ELISA Kit (AC2600) Quantitative inquiry ASET-2015 Human Visfatin ELISA Kit (AC3426) Quantitative inquiry ASET-2159 Human HAAO ELISA Kit (AC3570) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket